Published in Women's Health Weekly, August 5th, 1996
In a study of 61 patients with adenocarcinoma in situ, Wolf's team observed the incidence of residual disease in the uterus after preinvasive cells were removed by cone biopsy (Obstet Gynecol 1996;88:82-86). The Houston investigators found that patients with positive cone biopsy margins had a 53% incidence of residual disease. Patients with negative cone biopsy margins had a 33% incidence of residual disease.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly